Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Work
Year: 2009
Type: article
Abstract: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor.
Source: New England Journal of Medicine
Authors Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John W. Eikelboom, Jonas Oldgren +15 more
Institutions Population Health Research Institute, Hamilton Health Sciences, McMaster University, Lankenau Institute for Medical Research, Boehringer Ingelheim (United States) +9 more
Cites: 18
Cited by: 10,800
Related to: 10
FWCI: 384.1
Citation percentile (by year/subfield): 99.99
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze